Partneringreview 2006 - Therapy area (volume 2)

Table of Contents

INTRODUCTION

• About Partneringreview
• Full contents of Partneringreview 2006
• Review of deal making in 2005
• Deals announced by therapy area

VOLUME 2: THERAPY AREA

Chapter 1: Oncology

• Deals in the oncology therapy area by company
• Deals in the oncology therapy area by industry focus
• Deals in the oncology therapy area by development stage

Chapter 2: Infectious disease

• Deals in the infectious disease therapy area by company
• Deals in the infectious disease therapy area by industry focus
• Deals in the infectious disease therapy area by development stage

Chapter 3: Cardiovascular/Circulatory

• Deals in the cardiovascular/circulatory therapy area by company
• Deals in the cardiovascular/circulatory therapy area by industry focus
• Deals in the cardiovascular/circulatory therapy area by development stage

Chapter 4: Central Nervous System

• Deals in the central nervous system therapy area by company
• Deals in the central nervous system therapy area by industry focus
• Deals in the central nervous system therapy area by development stage

Chapter 5: Autoimmune/Inflammation

• Deals in the autoimmune/inflammation therapy area by company
• Deals in the autoimmune/inflammation therapy area by industry focus
• Deals in the autoimmune/inflammation therapy area by development stage

Chapter 6: Metabolism

• Deals in the metabolism therapy area by company
• Deals in the metabolism therapy area by industry focus
• Deals in the metabolism therapy area by development stage

Chapter 7: Respiratory

• Deals in the respiratory therapy area by company
• Deals in the respiratory therapy area by industry focus
• Deals in the respiratory therapy area by development stage

Chapter 8: Gastrointestinal

• Deals in the gastrointestinal therapy area by company
• Deals in the gastrointestinal therapy area by industry focus
• Deals in the gastrointestinal therapy area by development stage

Chapter 9: Musculoskeletal

• Deals in the musculoskeletal therapy area by company
• Deals in the musculoskeletal therapy area by industry focus
• Deals in the musculoskeletal therapy area by development stage

Chapter 10: Sensory Organ/Oral Health

• Deals in the sensory organ/oral health therapy area by company
• Deals in the sensory organ/oral health therapy area by industry focus
• Deals in the sensory organ/oral health therapy area by development stage

Chapter 11: Genitourinary/Gynecology

• Deals in the genitourinary/gynecology therapy area by company
• Deals in the genitourinary/gynecology therapy area by industry focus
• Deals in the genitourinary/gynecology therapy area by development stage

Chapter 12: Dermatology

• Deals in the dermatology therapy area by company
• Deals in the dermatology therapy area by industry focus
• Deals in the dermatology therapy area by development stage

Chapter 13: Blood/Lymphatic System

• Deals in the blood/lymphatic system therapy area by company
• Deals in the blood/lymphatic system therapy area by industry focus
• Deals in the blood/lymphatic system therapy area by development stage

Chapter 14: Accident/Hospital/Trauma

• Deals in the accident/hospital/trauma therapy area by company
• Deals in the accident/hospital/trauma therapy area by industry focus
• Deals in the accident/hospital/trauma therapy area by development stage

Chapter 15: List of deals

Tables

• Table 1 Top oncology area dealmaking companies in 2005
• Table 2 Top infectious disease area dealmaking companies in 2005
• Table 3 Top cardiovascular/circulatory area dealmaking companies in 2005
• Table 4 Top central nervous system area dealmaking companies in 2005
• Table 5 Top autoimmune/inflammation area dealmaking companies in 2005
• Table 6 Top metabolism area dealmaking companies in 2005
• Table 7 Top respiratory area dealmaking companies in 2005
• Table 8 Top gastrointestinal area dealmaking companies in 2005
• Table 9 Top musculoskeletal area dealmaking companies in 2005
• Table 10 Top sensory organ/oral health area dealmaking companies in 2005
• Table 11 Top genitourinary/gynecology area dealmaking companies in 2005
• Table 12 Top dermatology area dealmaking companies in 2005
• Table 13 Top blood/lymphatic system area dealmaking companies in 2005
• Table 14 Top accident/hospital/trauma area dealmaking companies in 2005

Figures

• Fig. i.1 Deals announced by therapy focus
• Fig. 1.1 Announcements in the oncology therapy area by company
• Fig. 1.2 Announcements in the oncology therapy area by industry sector
• Fig. 1.3 Announcements in the oncology therapy area by development stage
• Fig. 2.1 Announcements in the infectious disease therapy area by company
• Fig. 2.2 Announcements in the infectious disease therapy area by industry sector
• Fig. 2.3 Announcements in the infectious disease therapy area by development stage
• Fig. 3.1 Announcements in the cardiovascular/circulatory therapy area by company
• Fig. 3.2 Announcements in the cardiovascular/circulatory therapy area by industry sector
• Fig. 3.3 Announcements in the cardiovascular/circulatory therapy area by development
• Fig. 4.1 Announcements in the central nervous system therapy area by company
• Fig. 4.2 Announcements in the central nervous system therapy area by industry sector
• Fig. 4.3 Announcements in the central nervous system therapy area by development stage
• Fig. 5.1 Announcements in the autoimmune/inflammation therapy area by company
• Fig. 5.2 Announcements in the autoimmune/inflammation therapy area by industry sector
• Fig. 5.3 Announcements in the autoimmune/inflammation therapy area by development stage
• Fig. 6.1 Announcements in the metabolism therapy area by company
• Fig. 6.2 Announcements in the metabolism therapy area by industry sector
• Fig. 6.3 Announcements in the metabolism therapy area by development stage
• Fig. 7.1 Announcements in the respiratory therapy area by company
• Fig. 7.2 Announcements in the respiratory therapy area by industry sector
• Fig. 7.3 Announcements in the respiratory therapy area by development stage
• Fig. 8.1 Announcements in the gastrointestinal therapy area by company
• Fig. 8.2 Announcements in the gastrointestinal therapy area by industry sector
• Fig. 8.3 Announcements in the gastrointestinal therapy area by development stage
• Fig. 9.1 Announcements in the musculoskeletal therapy area by company
• Fig. 9.2 Announcements in the musculoskeletal therapy area by industry sector
• Fig. 9.3 Announcements in the musculoskeletal therapy area by development stage
• Fig. 10.1 Announcements in the sensory organ/oral health therapy area by company
• Fig. 10.2 Announcements in the sensory organ/oral health therapy area by industry sector
• Fig. 10.3 Announcements in the sensory organ/oral health therapy area by development
• Fig. 11.1 Announcements in the genitourinary/gynecology therapy area by company
• Fig. 11.2 Announcements in the genitourinary/gynecology therapy area by industry sector
• Fig. 11.3 Announcements in the genitourinary/gynecology therapy area by development
• Fig. 12.1 Announcements in the dermatology therapy area by company
• Fig. 12.2 Announcements in the dermatology therapy area by industry sector
• Fig. 12.3 Announcements in the dermatology therapy area by development stage
• Fig. 13.1 Announcements in the blood/lymphatic system therapy area by company
• Fig. 13.2 Announcements in the blood/lymphatic system therapy area by industry sector
• Fig. 13.3 Announcements in the blood/lymphatic system therapy area by development stage
• Fig. 14.1 Announcements in the accident/hospital/trauma therapy area by company
• Fig. 14.2 Announcements in the accident/hospital/trauma therapy area by industry sector
• Fig. 14.3 Announcements in the accident/hospital/trauma therapy area by development